No Pharmacokinetic Interaction Between the Hepatitis C Virus Inhibitors Elbasvir/Grazoprevir and Famotidine or Pantoprazole

Use of agents to suppress gastric acid secretion is common among patients with hepatitis C virus (HCV) infection. The aims of this open‐label, three‐period, fixed‐sequence study were to evaluate the effect of famotidine and pantoprazole on the pharmacokinetics and safety of elbasvir/grazoprevir fixe...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, H‐P, Vaddady, P, Guo, Z, Liu, F, Panebianco, D, Levine, V, Caro, L, Butterton, JR, Iwamoto, M, Yeh, WW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593162/
https://www.ncbi.nlm.nih.gov/pubmed/28625018
http://dx.doi.org/10.1111/cts.12465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593162/
https://www.ncbi.nlm.nih.gov/pubmed/28625018
http://dx.doi.org/10.1111/cts.12465

Ejemplares similares